Mounjaro®
Starting from £179.99/mo
Start journey Learn moreStarting Wegovy for the first time means beginning at 0.25mg — a dose designed to let your body adjust, not to produce weight loss straight away. Most people notice changes in appetite within the first few weeks, though the full effect builds gradually over months. Wegovy (semaglutide) is a prescription-only medicine, so treatment only begins after a prescriber has assessed your suitability.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The 0.25mg starting dose can feel anticlimactic. You inject, you wait, and (for many people) not very much seems to happen. That is the point. The starter dose is not a therapeutic level; it exists so your system gets acquainted with semaglutide before the dose climbs. Think of it less as treatment beginning and more as a settling-in period.
Appetite changes, if you notice them, are usually subtle at first. Some people report feeling full a little sooner at meals. Others notice nothing obvious for several weeks. Both experiences are normal. What the first day of Wegovy feels like varies considerably between individuals, and there is no single right response.
The injection itself goes into the fatty tissue of the abdomen, thigh or upper arm. Rotate the site each week — the same spot used repeatedly can become irritated. The pen is pre-filled and pre-set; the mechanics are straightforward once you have read the Patient Information Leaflet that comes with it. If anything is unclear, our prescribers are reachable seven days a week.
According to the NHS patient information on semaglutide, the most common early effects are gastrointestinal: nausea, constipation, diarrhoea or indigestion. These tend to ease within days to a couple of weeks as the body adapts.
Wegovy does not switch appetite off overnight. The mechanism (semaglutide acting on GLP-1 receptors involved in hunger signalling and gastric emptying) takes time to build. In the STEP 1 clinical trial (68 weeks, semaglutide 2.4mg), participants lost an average of around 15% of body weight, but that result accumulated over more than a year of treatment at maintenance dose, not in the first month at 0.25mg.
A more realistic early measure is how comfortable titration feels. If the 0.25mg step produces significant nausea, your prescriber may suggest staying at that level a little longer before moving up. Pushing through to a higher dose faster does not accelerate long-term results; it usually just makes side effects harder to manage.
The honest answer to "when will I see results?" is: meaningful, visible change typically emerges somewhere between weeks eight and sixteen for most people. Earlier if you combine treatment with dietary changes; later if titration moves slowly due to side effects. More detail on what using Wegovy looks like over time can help set realistic expectations before you start.
If cost is a factor in your thinking, the Wegovy cost guide covers what private treatment typically involves, including what a legitimate price should always include.
Nausea is the most commonly reported early side effect. It is rarely severe at 0.25mg, but worth planning around. A light meal before your injection, staying hydrated and avoiding rich or fatty food in the hours afterwards can all reduce it. Some people find that taking their injection on a Thursday evening means any nausea has settled before the working week properly starts, and if you are wondering what the best time to take Wegovy for the first time actually is, others prefer a consistent day that fits around the school run or a regular weekly routine. The specific day matters less than picking one and sticking to it.
Other GI effects to be aware of include constipation, diarrhoea, reflux and burping. These appear in different combinations in different people. Diarrhoea and vomiting together raise a secondary concern: dehydration. If you cannot keep fluids down, that warrants medical attention rather than waiting it out.
Two symptoms require urgent help regardless of how long you have been on treatment. Severe stomach pain that spreads to the back (with or without vomiting) can indicate pancreatitis, which the MHRA flagged in a Drug Safety Update in January 2026 as an infrequent but serious risk with GLP-1 medicines. Signs of a serious allergic reaction (swelling of the face or throat, difficulty breathing) also require emergency care. Both are uncommon. Knowing about them matters anyway.
Injection-site reactions (redness, mild swelling or itching at the injection spot) are generally minor and resolve on their own. Rotating sites is the most effective prevention.
A few practical points are worth confirming before the pen arrives. Storage: Wegovy needs to be refrigerated at 2–8°C; the Patient Information Leaflet gives the exact window for room-temperature use when refrigeration is not possible, and that leaflet is the authority, not a rough guide from online. Tell any other clinician involved in your care (your GP, a dentist preparing you for surgery, anyone prescribing other medicines) that you are starting semaglutide.
If you take oral contraceptives, the NHS England guidance on weight management injections notes that semaglutide does not carry the same pill-absorption concern as tirzepatide, though discussing contraception with your prescriber is always sensible. Wegovy is not recommended during pregnancy, while breastfeeding, or if you are trying to conceive; nor is it licensed for anyone under eighteen.
If you would like to understand the full picture of how Wegovy works before starting, or want to read our guide for people using Wegovy for the first time, our clinical team at nume (sorry) our prescribers review every consultation personally. Check your eligibility and a GPhC-registered Independent Prescriber will assess your details the same day.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.